Clinical trial
Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of…
NCT00428129 · ThromboGenics, Industry · Terminated
Key facts
| NCT number | NCT00428129 |
|---|---|
| Title | Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT |
| Official title | An Open Label Clinical Trial of Microplasmin Administered Via the Trellis-8 Infusion System for the Treatment of Acute Iliofemoral Deep Vein Thrombosis |
| Acronym | MAX-DVT |
| Lead sponsor | ThromboGenics, Industry |
| Collaborators | Bacchus Vascular Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis |
| Intervention type | Drug |
| Interventions | microplasmin |
| Enrollment | 6 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jan 29, 2007 |
| Last update posted | Apr 7, 2014 |
| Countries | Ireland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: